Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma: A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A

Cancer

Volumn 77, Issue 11, 1996, Pages 2371-2378

  Sundfør, Kolbein ^a   Tropé, Claes G ^a   Högberg, Thomas ^b,c   Onsrud, Mathias ^d   Kœrn, Janne ^a   Simonsen, Ernst ^b,c   Bertelsen, Kamma ^e   Westberg, Ronny ^f  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c University Hospital   (Norway)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f BRISTOL MYERS SQUIBB   (United States)

Author keywords

Adjuvant; Carcinoma; Cervix neoplasms; Chemotherapy; Cisplatin; Fluorouracil; Radiotherapy; Randomized controlled trials; Squamous cell

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; METASTASIS; MUCOSA INFLAMMATION; MULTICENTER STUDY; NEPHROTOXICITY; NEUROTOXICITY; OTOTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, HIGH-ENERGY; REMISSION INDUCTION; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0029956050     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19960601)77:11<2371::aid-cncr28>3.0.co;2-t     Document Type: Article

References (24)

1. Petterson F. FIGO's Annual report on the results of treatment in gynecological cancer. Vol. 19. Stockholm: Radiumhemmet, 1985:27-49.
2. Malkasian GD, Decker DG, Jorgensen EP. Chemotherapy of carcinoma of ther cervix. Gynecol Oncol 1977;5:109-20.
3. Thigpen T, Shingleton H, Homesly H, Lagasse L, Blessing J. Cisplatinum in treatment of advanced or recurrent squamous cell carcinoma for the cervix: a phase II study of the Gynecologic Oncology Group. Cancer 1981;48:899-903.
4. Muscato MS, Perry MC, Yarbro JW. Chemotherapy of cervical carcinoma. Semin Oncol 1982;9:373-87.
5. Bonomi P, Blessing JA, Stehman FB, DiSaia PJ, Walton L, Major FJ. Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol 1985;3:1079-85.
6. Kish JA, Ensley JF, Jacobs J, Weaver A, Cummings G, Al-Sarraff M. A randomized Trial of Cisplatin (CACP) + 5-fluorouracil (5-FU) Infusion and CACP + 5-FU Bolus for Recurrent and Advanced Squamous Cell Carcinoma of the Head and Neck. Cancer 1985;56:2740-4.
7. Beaupain R, Dionet C. Effects of combined treatments of cis-diamminedichloro-platinum UII), 5-fluorouracil, and x-rays on growth of human cancer nodules maintained in continuous organotypic culture. Cancer Res 1985;45:3150-4.
8. Schabel FM Jr, Trader MW, Laster WR Jr, Corbett TH, Griswold DP Jr. Cis-dichlorodiammineplatinum (II): combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat Rep 1979;63:1459-73.
9. Teicher BA, Cucchi CA, Lee JB, Flatow JL, Rosowsky A, Frei E III. Alkylating Agents: In Vitro Studies of Cross-Resistance Patterns in Human Cell Lines. Cancer Res 1986;46:4379-83.
10. Simonsen E, Högberg T, Persson H, Stendahl U. Advanced primary or recurrent squamous cell carcinoma of the cervix uteri treated with chemotherapy, combination used: cisplatinum and 5-fluorouracil. In: Proceedings of the European Conference on Clinical Oncology and Cancer Nursing; 1987 Nov 1-4; Madrid Federation of European Cancer Societies, 1987;791.
11. Kaern J, Tropé C, Sundfør K, and Kristensen GB. Cisplatin/ 5-fluorouracil treatment of recurrent cervical carcinoma: A phase II study with long-term follow-up. Gynecol Oncol 1996;60:387-92.
12. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
13. Chauvergne J, Rohart J, Heron JF, Fargeot P, Berlie J, David P, et al. Randomized phase III trial of neo-adjuvant chemotherapy (CT) + radiotherapy (RT) vs. RT in stage IIB, III carcinoma of the cervix (CACX): a cooperative study of French Oncology Centers. Proc Am Soc Clin Oncol 1988;7:136.
14. Tobias J, Buxton EJ, Blackledge G, Mould JJ, Monaghan J, Spooner D, et al. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer. Cancer Chemother Pharmacol 1990;26(Suppl):59-62.
15. Souhami L, Gil RA, Allan SE, Canary PCV, Araujo CCM, Pinto LHJ, et al. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. J Clin Oncol 1991;9:970-7.
16. Cárdenas J, Olguin A, Figueroa F, Pena J, Becerra F, Huizar R. Neoadjuvant chemotherapy (CT) in cervical carcinomas (CC) PEC + RT vs. RT. Preliminary results. Proc Eur Conf Clin Oncol 1991;6:124S.
17. Tattersall MHN, Lorvidhaya V, Vootiprux V, Cheirsilpa A, Wong F, Azhar T, et al. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. J Clin Oncol 1995;13:2:444-51.
18. Steel GG. The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiother Oncol 1988;11:31-53.
19. Stephens TC, Steel GG. Regeneration of tumors after cytotoxic treatment. In: Meyn RE, Withers HR, editors. Radiation biology in cancer research. New York: Raven Press, 1980:385.
20. Withers HR, Taylor JMF, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-46.
21. Ozols RF, Masuda H, Hamilton TC. Keynote address: mechanisms of cross-resistance between radiation and antineoplastic drugs. NCI Monogr 1988;6:159-65.
22. Carmichael J, Hickson ID. Keynote address: mechanisms of cellular resistance to cytotoxic drugs and x-irradiation. Int J Radiat Oncol Biol Phys 1991;20:197-202.
23. Sardi J, Sananes C, Giarolli A, Bayo J, Rueda NG, Vighi S, et al. Results of a prospective randomized trial with neoadjuvant chemotherapy in stage 1b, bulky, squamous carcinoma of the cervix. Gynecol Oncol 1993;49:156-65.
24. Resbeut M, Noirclerc M, Viens P, d'Ercole C, Houvenaeghel G, Boubli L, et al. Concomitant chemotherapy and radiotherapy in the treatment of advanced cervix carcinomas. (Fr) Bull Cancer 1993;80:984-93.